For decades, high-quality off-patent medicines have been known as “generics” – yet there is nothing generic about their impact.
Containing the same active ingredient and meeting the same standards for quality, safety and efficacy as branded medicines, they deliver trusted treatments at a significantly lower cost. They make therapies more accessible while helping healthcare systems reinvest in patient care and innovation. 🔬
At Tiefenbacher Group, we believe the name “affordable medicines” better reflects the value these medicines create for patients and societies worldwide. 💙
